243
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Impact of Lung Function Parameters on Sleep Among Aboriginal Australians – A Polysomnography and Spirometry Relationship Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 449-464 | Received 01 Mar 2023, Accepted 22 May 2023, Published online: 09 Jun 2023

References

  • Australian Institute of Health and Welfare. Australian Burden of Disease Study: Impact and Causes of Illness and Death in Aboriginal and Torres Strait Islander People 2018. Canberra: AIHW; 2022.
  • Heraganahally SS, Ghimire RH, Howarth T, Kankanamalage OM, Palmer D, Falhammar H. Comparison and outcomes of emergency department presentations with respiratory disorders among Australian indigenous and non-indigenous patients. BMC Emerg Med. 2022;22:11. doi:10.1186/s12873-022-00570-3
  • Heraganahally SS, Silva SAMS, Howarth TP, Kangaharan N, Majoni SW. Comparison of clinical manifestation among Australian Indigenous and non‐indigenous patients presenting with pleural effusion. Intern Med J. 2022;52(7):1232–1241. doi:10.1111/imj.15310
  • Heraganahally SS, Howarth T, White E, Sorger L, Biancardi E, Ben Saad H. Lung function parameters among Australian aboriginal ‘apparently healthy’ adults: an Australian caucasian and Global Lung Function Initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med. 2021;15:833–843. doi:10.1080/17476348.2021.1847649
  • Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease in aboriginal patients of the Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis. 2019;14:2205–2217. doi:10.2147/COPD.S213947
  • Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study. Intern Med J. 2020;50:1505–1513. doi:10.1111/imj.14718
  • Howarth T, Saad HB, Perez AJ, Atos CB, White E, Heraganahally SS. Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between indigenous Australians and Australian caucasian adults. PLoS One. 2021;16(4):e0248900. doi:10.1371/journal.pone.0248900
  • Sze DF, Howarth TP, Lake CD, Ben Saad H, Heraganahally SS. Differences in the spirometry parameters between indigenous and non-indigenous patients with COPD: a matched control study. Int J Chron Obstruct Pulmon Dis. 2022;17:869–881. doi:10.2147/COPD.S361839
  • Seyedshahabedin MM, Howarth TP, Mo L, Biancardi E, Heraganahally SS. Flexible bronchoscopy indications and outcomes between indigenous and non-indigenous patients in the Northern Territory of Australia. Int Med J. 2022. doi:10.1111/imj.15865
  • Heraganahally SS, Howarth TP, Sorger L. Chest computed tomography findings among adult Indigenous Australians in the Northern Territory of Australia. J Med Imaging Radiat Oncol. 2022;66:337–344. doi:10.1111/1754-9485.13295
  • Heraganahally SS, Howarth TP, Lloyd A, White E, Veale A, Ben Saad H. The prevalence of bronchodilator responsiveness ‘asthma’ among adult indigenous Australians referred for lung function testing in the top end Northern Territory of Australia. J Asthma Allergy. 2022;15:1305–1319. doi:10.2147/JAA.S376213
  • Kruavit A, Fox M, Pearson R, Heraganahally S. Chronic respiratory disease in the regional and remote population of the Northern Territory top end: a perspective from the specialist respiratory outreach service. Aust J Rural Health. 2017;25:275–284. doi:10.1111/ajr.12349
  • McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180:692–700. doi:10.1164/rccm.200903-0347PP
  • Lee R, McNicholas WT. Obstructive sleep apnea in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2011;17:79–83. doi:10.1097/MCP.0b013e32834317bb
  • Zhang P, Chen B, Lou H, et al. Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary disease in China. BMC Pulm Med. 2022;22:16. doi:10.1186/s12890-021-01780-4
  • Blunden S, Yiallourou S, Fatima Y. Sleep health and its implications in First Nation Australians: a systematic review. Lancet Reg Health West Pac. 2022;21:100386. doi:10.1016/j.lanwpc.2022.100386
  • Heraganahally SS, Rajaratnam B, Silva SAAS, et al. Obstructive sleep apnoea and cardiac disease among aboriginal patients in the Northern Territory of Australia. Heart Lung Circ. 2021;30:1184–1192. doi:10.1016/j.hlc.2021.01.007
  • Benn E, Wirth H, Short T, Howarth T, Heraganahally SS. The Top End Sleepiness Scale (TESS): a new tool to assess subjective daytime sleepiness among indigenous Australian adults. Nat Sci Sleep. 2021;13:315–328. doi:10.2147/NSS.S298409
  • Heraganahally SS, Kruavit A, Oguoma VM, et al. Sleep apnoea among Australian aboriginal and non-aboriginal patients in the Northern Territory of Australia—a comparative study. Sleep. 2020;43(3):zsz248. doi:10.1093/sleep/zsz248
  • Woods CE, McPherson K, Tikoft E, et al. Sleep disorders in aboriginal and torres strait islander people and residents of regional and remote Australia. J Clin Sleep Med. 2015;15:1263–1271. doi:10.5664/jcsm.5182
  • Yiallourou SR, Maguire GP, Carrington MJ. Sleep quantity and quality and cardiometabolic risk factors in Indigenous Australians. J Sleep Res. 2021;30:e13067. doi:10.1111/jsr.13067
  • Macniven R, Richards J, Gubhaju L, et al. Physical activity, healthy lifestyle behaviors, neighborhood environment characteristics and social support among Australian aboriginal and non-aboriginal adults. Prev Med Rep. 2016;3:203–210. doi:10.1016/j.pmedr.2016.01.006
  • LaGrappe D, Massey L, Kruavit A, et al. Sleep disorders among Aboriginal Australians with Machado-Joseph disease: quantitative results from a multiple methods study to assess the experience of people living with the disease and their caregivers. Neurobiol Sleep Circadian Rhythm. 2022;12:100075. doi:10.1016/j.nbscr.2022.100075
  • Mehra S, Ghimire RH, Mingi JJ, et al. Gender differences in the clinical and polysomnographic characteristics among Australian Aboriginal patients with obstructive sleep apnea. Nat Sci Sleep. 2020;12:593–602. doi:10.2147/NSS.S258330
  • Santos MA, Aguiar M, Sacramento V, et al. Obstructive sleep apnea severity and lung function. Eur Respir J. 2018;52(62):A2522.
  • Emilsson ÖI, Sundbom F, Ljunggren M, et al. Association between lung function decline and obstructive sleep apnoea: the ALEC study. Sleep Breath Schlaf Atm. 2021;25:587–596. doi:10.1007/s11325-020-02086-1
  • Mehfooz N, Siraj F, Shabir A, et al. Spirometric abnormalities in patients with sleep-related breathing disorders. J Fam Med Prim Care. 2021;10:1009–1014. doi:10.4103/jfmpc.jfmpc_1018_20
  • Vukoja M, Milicic D, Bokan A, et al. Lung function in patients with obstructive sleep apnoea. ERJ Open Res. 2017;3(1):14.
  • Ashraf M, Shaffi SA, BaHammam AS. Spirometry and flow-volume curve in patients with obstructive sleep apnea. Saudi Med J. 2008;29:198–202.
  • Rouatbi S, Ghannouchi I, Kammoun R, Ben Saad H. The ventilatory and diffusion dysfunctions in obese patients with and without obstructive sleep apnea-hypopnea syndrome. J Obes. 2020;10:8075482. doi:10.1155/2020/8075482
  • Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg J. 2016;45(1):43. doi:10.1186/s40463-016-0156-0
  • Martani M, Bourahli MK, Bougrida M, Ben Saad H. Plethysmographic data and profile of North-African patients with severe obstructive sleep apnea treated with continuous positive airway pressure. Expert Rev Respir Med. 2021;15:267–275. doi:10.1080/17476348.2021.1823834
  • Woods C, Usher K, Kerr L, Ferns J, Maguire G. Barriers and enablers to successful uptake of Continuous Positive Airway Pressure (CPAP) treatment for obstructive sleep apnoea for aboriginal and torres strait islander people. J Sleep Disord Treat Care. 2016;5:1–7.
  • Heraganahally SS, Howarth T, Mo L, Sorger L, Ben Saad H. Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases. Expert Rev Respir Med. 2021;15:1229–1238. doi:10.1080/17476348.2021.1928496
  • Heraganahally SS, Howarth T, Sorger L, Ben Saad H. Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease. PLoS One. 2022;17:2. doi:10.1371/journal.pone.0263744
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–545. doi:10.1093/sleep/14.6.540
  • Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): volume 5—remoteness structure, 2011. ABS cat. no. 1270.0.55.005. Canberra: Australian Bureau of Statistics; 2013.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–1343. doi:10.1183/09031936.00080312
  • Stanojevic S, Kaminsky DA, Miller M, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. doi:10.1183/13993003.01499-2021
  • Heraganahally S, Howarth TP, White E, Ben Saad H. Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study. BMJ Open Respir Res. 2021;8:e001135. doi:10.1136/bmjresp-2021-001135
  • Heraganahally SS, Ponneri TR, Howarth TP, Saad HB. The effects of inhaled airway directed pharmacotherapy on decline in lung function parameters among Indigenous Australian adults with and without underlying airway disease. Int J Chron Obstruct Pulmon Dis. 2021;16:2707–2720. doi:10.2147/COPD.S328137
  • Heraganahally SS, Kerslake C, Issac S, et al. Outcome of public hospital-funded continuous positive airway therapy device for patients with obstructive sleep apnoea: an Australian perspective study. Sleep Vigil. 2020;4:195–204. doi:10.1007/s41782-020-00114-4
  • Heraganahally SS, Howarth TP, Perez AJ, et al. Acceptability, adaptability and adherence to CPAP therapy among aboriginal Australians with OSA - “The A5 study”. Sleep Med. 2023;102:147–156. doi:10.1016/j.sleep.2022.12.024
  • Heraganahally SS, Mortimer N, Howarth T, et al. Utility and outcomes among Indigenous and non-Indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population. Aust J Rural Health. 2021;29:918–926. doi:10.1111/ajr.12782
  • Shawon MSR, Perret JL, Senaratna CV, Lodge C, Hamilton GS, Dharmage SC. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: a systematic review. Sleep Med Rev. 2017;32:58–68. doi:10.1016/j.smrv.2016.02.007
  • McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest. 2017;152:1318–1326. doi:10.1016/j.chest.2017.04.160
  • Borekci S, Hacoğlu Y, Musellim B. Investigation of obstructive sleep apnea in adult non-cystic fibrosis bronchiectasis patients. Eur Respir J. 2019;54(63):A631.
  • Erdem E, Ersu R, Karadag B, et al. Effect of night symptoms and disease severity on subjective sleep quality in children with non-cystic-fibrosis bronchiectasis. Pediatr Pulmonol. 2011;46:919–926. doi:10.1002/ppul.21454
  • Faria Júnior NS, Urbano JJ, Santos IR, et al. Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: a cross-sectional study. PLoS One. 2017;12:10. doi:10.1371/journal.pone.0185413
  • Yang X, Tang X, Cao Y, et al. The bronchiectasis in COPD-OSA overlap syndrome patients. Int J Chron Obstruct Pulmon Dis. 2020;15:605–611. doi:10.2147/COPD.S243429
  • Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol. 2003;35:477–483. doi:10.1002/ppul.10289
  • Howarth T, Heraganahally SS, Heraganahally SS. Bronchiectasis among adult first nations Indigenous people - a scoping review. Curr Respir Med Rev. 2022;19:36–51.
  • Howarth TP, Gahreman D, Saad HB, Ng L, Heraganahally SS. Correlation of spirometry indices to chest radiology in the diagnosis of chronic airway disease among regional and rural Indigenous Australians. Intern Med J. 2023. doi:10.1111/imj.16023
  • Wang D, Smith D, Huang H, Murray N, Thomas PS. Spirometry to identify moderate to severe obstructive sleep apnea. Am J Respir Crit Care Med. 2020;201:A4142–A4142.
  • Bednarek M, Plywaczewski R, Jonczak L, Zielinski J. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respir Int Rev Thorac Dis. 2005;72:142–149.
  • McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev. 2013;22:365–375. doi:10.1183/09059180.00003213
  • Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of confronting COPD international survey. Eur Respir J. 2002;20:799–805. doi:10.1183/09031936.02.03242002
  • Budhiraja R, Siddiqi TA, Quan SF. Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med. 2015;11:259–270. doi:10.5664/jcsm.4540
  • Luyster FS, Wang J, Sciurba FC, Bon J. Longitudinal associations between sleep disturbance and disease severity in patients with COPD. Sleep Sci Pract. 2020;4:12. doi:10.1186/s41606-020-00046-y
  • Martinez S, Sullivan J, Pasquale C, et al. Effect of two interventional strategies on improving continuous positive airway pressure adherence in existing COPD and obstructive sleep apnea patients: the O2VERLAP study. Chronic Obstr Pulm Dis. 2022;9:394–412. doi:10.15326/jcopdf.2022.0293
  • Jaoude P, Kufel T, El-Solh AA. Survival benefit of CPAP favors hypercapnic patients with the overlap syndrome. Lung. 2014;192:251–258. doi:10.1007/s00408-014-9555-z
  • Stanchina ML, Welicky LM, Donat W, Lee D, Corrao W, Malhotra A. Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med. 2013;9:767–772. doi:10.5664/jcsm.2916
  • Sterling KL, Pépin J-L, Linde-Zwirble W, et al. Impact of positive airway pressure therapy adherence on outcomes in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;206:197–205. doi:10.1164/rccm.202109-2035OC
  • Wang TY, Lo YL, Lin SM, et al. Obstructive sleep apnoea accelerates FEV1 decline in asthmatic patients. BMC Pulm Med. 2017;17(1):55. doi:10.1186/s12890-017-0398-2
  • Sullivan J, Pasquale C, Clark B, et al. Outcomes important to patients diagnosed with both COPD and sleep apnea: findings from the O2VERLAP study focus groups. Chronic Obstr Pulm Dis. 2022;9:45–54. doi:10.15326/jcopdf.2021.0268
  • Pal A, Howarth TP, Rissel C, et al. COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation. BMJ Open Resp Res. 2022;9:e001295. doi:10.1136/bmjresp-2022-001295
  • Heraganahally SS, Howarth TP, Issac S, et al. Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia – a retrospective cohort study. BMJ Open Resp Res. 2023;10:e001508. doi:10.1136/bmjresp-2022-001508
  • Lindfield M, Howarth TP, Perez AJ, et al. Obstructive sleep apnoea in Aboriginal Australians: polysomnographic outcomes and symptom perception post-CPAP implementation. Sleep Adv. 2023;4:1. doi:10.1093/sleepadvances/zpad015